HPHA.HM Heidelberg Pharma AG

- EUR
Market cap
-
P/E
-
P/B
7.85x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Aug 2026.

Is HPHA.HM undervalued?

Graham number

The Graham number of Heidelberg Pharma AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Heidelberg Pharma AG fundamental analysis

No fundamental analysis for Heidelberg Pharma AG yet.

Heidelberg Pharma AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.